Rehabilitation and Survivorship Considerations in Head and Neck Cancer​

Dr. Ron Karni shares best practices for assessing, diagnosing and treating head and neck lymphedema (HNL) using case studies and recent clinical data.

  • Pre-rehabilitation and rehabilitation are increasingly emphasized in cancer care.
  • Lymphedema is the cardinal side effect of HN cancer treatment.
  • Flexitouch® is the only FDA-approved device for managing HNL.


Click the timestamps below to jump to video segments on YouTube:

0:00 – Intro / the changing demographic of HNC patients

6:39 Side effects from head and neck cancer

9:39 Rehabilitation team and managing cancer care

13:15 Cancer treatment: Doctor vs. Patient perspectives

18:20 Importance of prehab, rehabilitation, and lymphedema therapy for HNC survivors

22:50 Only 15% of survivors utilize lymphedema therapy

23:47 Five key things to know about lymphedema

29:29 How to identify and measure lymphedema

34:45 Patient examples: internal lymphedema

41:39 Challenges with traditional lymphedema care

43:02 Why patients need the Flexitouch device

45:56 Vanderbilt Clinical Trial – the first RCT for HN Lymphedema

54:58 How does external treatment help internal swelling?

57:05 When to refer patients for the Flexitouch?

59:29 How can you diagnose lymphedema if you are not measuring internally?

1:02:42 Dr. Karni shares what he has seen with the Flexitouch

Presented By

  • Ron Karni, MD